Concentration profile of tobramycin in exhaled breath condensate after inhalation of a single dose: A pilot study (original) (raw)

Journal of Drug Delivery Science and Technology, 2021

Abstract

Abstract Exhaled breath condensate (EBC) has recently emerged as a noninvasive alternative to obtain a respiratory sample to study airway drug concentration. The aim of this work is to explore the feasibility of EBC to measure tobramycin concentration using a synthesized sodium dodecyl sulfate-capped silver nanoprobe as a pilot study. In this study, EBC was collected from healthy volunteers using a lab-made setup after inhalation of 150 mg tobramycin to obtain a full concentration-time curve. Tobramycin concentration in EBC was measured by a synthesized sodium dodecyl sulfate-capped silver nanoparticle probe using λ522/λ400 UV absorption ratio on UV–Vis spectrophotometer. Tobramycin was detectable in EBC 4 h post inhalation with a limit of detection of 0.5 ng/mL. Mean (SD) Cmax and AUClast were 31.5 (6.8) ng/mL and 53.2 (25.5) ng.h/mL, respectively. Results demonstrate the possibility of investigating the bioequivalency of inhaled formulations of tobramycin employing EBC samples.

anahita azarbayjani hasn't uploaded this paper.

Let anahita know you want this paper to be uploaded.

Ask for this paper to be uploaded.